Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000259397

Medchemexpress LLC N-(1H-benzimidazol-2-yl)-3-(1H-pyrrol-1-yl)benzamide | 1190277-80-5 | MFCD13758448 | 98.1% | C18H14N4O | 10MG
SDP

Supplier:  Medchemexpress LLC HY13755210MG

Encompass_Preferred

MKI-1 is a small-molecule research inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) that inhibits MASTL with an IC50 of 9.9 μM. It has demonstrated antitumor and radiosensitizing activity in breast cancer models through activation of PP2A and reduces c-Myc stability in cellular assays. Supplied as an off-white to light yellow solid with reported purity of ~98% and high DMSO solubility.

  • Inhibits MASTL with IC50 of 9.9 μM.
  • Demonstrates antitumor and radiosensitizer activity via PP2A activation.
  • Active in breast cancer cell assays at low micromolar concentrations.
  • Reduces c-Myc phosphorylation and stability in cells.
  • Off-white to light yellow solid with high reported purity (~98%).
  • Soluble in DMSO at high concentration (about 250 mg/mL).
  • Intended for in vitro research use only.

Catalog No. 50-002-59397


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.